Seeking Therapeutic Interventions and Vaccine Innovations for Hepatitis B and Hepatitis D Viruses
A global pharmaceutical company with cutting-edge capabilities in drug development and a history of successful academic collaborations wishes to identify infectious disease therapeutics and vaccines in European institutes, targeting Hepatitis B and Hepatitis D virus infection.
Our client wishes to identify technologies, research projects and spin‑out companies at any stage of development, from basic research to Phase I, focusing on the treatment of Hepatitis B and/or Hepatitis D. Vaccines, novel therapeutics and selective targeting ...
To see the full details and submit your response please register now
Benefits of registration:
- Receive updates on the latest industry calls
- Quickly and easily respond to calls via your dashboard
- Build your academic profile